Q3 2017 Holdings
Filed 2017-11-14 | 68 holdings | $20.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-11-16) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $6.3M | 20,000 | 31.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $5.8M | 65,000 | 28.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $3.6M | 125,000 | 18.1% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $1.7M | 565,000 | 8.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.3M | 70,000 | 6.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 30,000 | 5.4% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $205.0K | 25,000 | 1.0% |
| Celgene Corp(CELG) | COM | 151020104 | $10.9K | 75,000 | 0.1% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $7.5K | 150,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $7.0K | 500,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $6.6K | 80,000 | 0.0% |
| Clovis Oncology IncCall | CALL | 189464900 | $6.2K | 75,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $5.6K | 40,000 | 0.0% |
| Cigna Corporation | COM | 125509109 | $5.0K | 26,500 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.9K | 100,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $4.8K | 75,000 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $4.5K | 85,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $4.5K | 28,500 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.4K | 400,000 | 0.0% |
| K2m Group Hldgs Inc | COM | 48273J107 | $4.2K | 200,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $3.9K | 125,000 | 0.0% |
| Medicines Co | COM | 584688105 | $3.7K | 100,000 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $3.5K | 30,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $3.5K | 55,000 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $3.4K | 40,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $3.4K | 125,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $3.4K | 75,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $3.3K | 100,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $3.2K | 25,000 | 0.0% |
| Danaher Corp del(DHR) | COM | 235851102 | $3.0K | 35,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $3.0K | 200,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $2.8K | 90,000 | 0.0% |
| Merus N VA | COM | N5749R100 | $2.8K | 140,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $2.7K | 50,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $2.6K | 70,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $2.2K | 40,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $2.1K | 60,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $2.0K | 275,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.0K | 250,000 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $2.0K | 30,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $1.7K | 50,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $1.7K | 17,500 | 0.0% |
| Express Scripts Hldg Co | COM | 30219G108 | $1.6K | 25,000 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $1.6K | 350,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.6K | 50,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $1.5K | 125,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $1.5K | 60,000 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $1.4K | 125,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.3K | 90,000 | 0.0% |
| Diplomat Pharmacy Inc(DPLOEUR) | COM | 25456K101 | $1.2K | 60,000 | 0.0% |